Generic pharmaceutical companies must embrace innovation and adopt technology if they are to stay competitive at both domestic and global level. Manufacturers of generic drugs must be able to prove that the compounds they produce are comparable to the brand-name drug while maintaining and/or improving the cost effectiveness of the drug’s production.
Today, there are thousands of generic drugs available and all are manufactured and inspected under the same strict quality guidelines as a brand. Drug research is costly, and patent protection gives brand-name manufacturers at least 20 years to recover those costs—costs that generic manufacturers do not have.
At SunBio IT Solutions, we understand the importance of cost optimization and therefore our services are designed to minimize the lab operating costs while guaranteeing regulatory compliance.